Skip to main content

Animations

Illustrated close up of DNA.

Research Tools Catalog

To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.

Helpful Resources

  • Illustrated adjacent hexagons.

    Sponsored Tools Program

    Learn more about how MJFF can help share your tools.

  • Illustrated Parkinson's Disease Research Tools Consortium logo.

    Tools Consortium

    MJFF is working with industry to develop priority tools.

  • Illustrated brain on a presentation display.

    Preclinical Models

    Learn more about the various in vivo models used in Parkinson's disease research.

Find a Research Tool

Filter by Tool Type or Gene/Protein Type to Organize Results

* = MJFF does not control pricing or terms of availability for this tool. 

Filters
Sort by
Order
Filters
Sort by
Order
Sort by
Order
Results (277)
Sort by:
LRRK2 R1441C Mouse*
Mouse Model
Transgenic mice expressing full length LRRK2 with R1441C mutation driven by CMV enhancer and PDGFB promoter/enhancer elements. Model was generated and deposited by Darren Moore at Van Andel Research Institute and Valina Dawson at Johns Hopkins University through the MJFF Sponsored Tools Program (available through cryorecovery). RRID:IMSR_JAX:016576
  • LRRK2
LRRK2 R1441G KI MEF
Immortalized Cell
Mouse embryonic fibroblast line with knockin of the LRRK2 R1441G mutation.  Expected availability: Late 2025
  • LRRK2
LRRK2 R1441G Mouse
Mouse Model
Transgenic mice overexpressing a mutant form (R1441G) of human LRRK2 directed by its endogenous promoter/enhancer regions on the BAC transgene. RRID:IMSR_JAX:018786
  • LRRK2
LRRK2 S910A/S935A Knockin Mouse*
Mouse Model
Mice carrying LRRK2 S910A and S935A mutations in exon 21. Model was generated and deposited by Dario Alessi at University of Dundee through the MJFF Sponsored Tools Program (available through cryorecovery). RRID:IMSR_JAX:028801  
  • LRRK2
LRRK2 T1348N Mouse
Mouse Model
Mice expressing the T1348N mutant (GTPase-dead) form of LRRK2. RRID:IMSR_JAX:021829
  • LRRK2
LRRK2 Wild Type Overexpression Mouse*
Mouse Model
Hemizygous BAC LRRK2 mice that overexpress wild type human LRRK2 directed by the human LRRK2 promoter/enhancer regions on the BAC transgene. Model was generated and deposited by Chenjian Li at Mount Sinai School of Medicine through the MJFF Sponsored Tools Program (available through cryorecovery). RRID:IMSR_JAX:009610 
  • LRRK2
LRRK2 Wild-type Mouse
Mouse Model
Mice express a wild-type human LRRK2 gene directed by its endogenous promoter/enhancer regions on the BAC transgene. The human LRRK2 protein expression is approximately 5-fold over endogenous mouse LRRK2. RRID:IMSR_JAX:013725
  • LRRK2
LRRK2 Y1699C Mouse*
Mouse Model
Transgenic mice expressing LRRK2 Y1699C mutation. Model was generated and deposited by Heather Melrose at Mayo Clinic College of Medicine and Matthew Farrer at University of British Columbia through the MJFF Sponsored Tools Program (available through cryorecovery). RRID:IMSR_JAX:021913  
  • LRRK2
MCI-PARK Mouse*
Mouse Model
Homozygous knockout mice targeting Ndufs2 (NADH:ubquinone oxidoreductase core subunit S2) specifically in dopaminergic neurons. Mice with floxed Ndufs2 allele were crossed with mice expressing Cre recombinase under the control of Slc6ac (dopamine transporter; DAT) promoter. Model was generated and deposited by D. James Surmeier at Northwestern University through the MJFF Sponsored Tools Program. RRID:IMSR_JAX:036313
  • Ndufs2
MCU Floxed DAT-Cre Mouse*
Mouse Model
MCU Floxed DAT-Cre mice were generated by crossing floxed exons 5 and 6 of the MCU gene (Zampese et al. 2022) with mice expressing Cre recombinase under the dopaminergic-specific DAT to induce knock-out of MCU (mitochondrial Ca2+ uniporter), resulting in the loss of MCU specifically in dopaminergic cells. Model was designed by D. James Surmeier at Northwestern University and made available through the MJFF Sponsored Tools Program. RRID:IMSR_JAX:038988
  • MCU
Have questions or need additional information?

Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page. 

"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD Mayo Clinic
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.